Navigating the perceived daunting aspects with gaining data from first-in-human studies, through to Proof-of-Concept and dose ranging studies should never be seen as complex or
time consuming. Logical approaches to optimize early phase clinical activities ensure the correct decisions can be critically made before future registration studies. The application of innovative strategies has proven that early phase clinical trials can be executed on time and within budget. A specialist panel of early phase industry professionals has been assembled for one day
round table discussions. Sharing their experiences with actual real case studies, from a range of different perspectives such as medical, regulatory, clinical, sponsor, and patients will be of major benefit to help develop your Early Phase strategy to Proof-of-Concept.